AAN April 1 - 2024 Supporting materials POSTER: Safety, Tolerability, and Efficacy of Brexpiprazole for the Treatment of Agitation Associated With Dementia due to Alzheimer’s Disease: a 12-Week Extension Trial POSTER: Effects of Brexpiprazole on Agitation Associated With Dementia due to Alzheimer’s Disease: Analysis of Pooled Response Data From two Phase 3 Fixed-Dose Trials
